Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Cancer Patients With Chemotherapy-Associated Anemia

NCT00661999 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00661999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00661999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Cancer Patients With Chemotherapy-Associated Anemia
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
March 31, 2009
Enrollment
502 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, leukemia, lymphoma, lymphoproliferative disorder, multiple myeloma and plasma cell neoplasm, precancerous condition, unspecified adult solid tumor, protocol specific